Hologic Inc. has announced that new clinical evidence on its AI-powered mammography solutions will be presented at the upcoming Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, Illinois. The studies focus on Hologic's 3DQuorum® imaging technology and the Genius AI® Detection solution. Early findings from a study led by Dr. Manisha Bahl at Massachusetts General Hospital indicate that the AI technology demonstrates similar performance to radiologists, detecting more cancers but with lower specificity, potentially flagging more false positives. Another study led by Professor Yan Chen compared the Genius AI® Detection solution with radiologists in reviewing challenging breast cancer cases. These results are part of Hologic's ongoing efforts to advance breast cancer detection technologies, with further data to be unveiled at RSNA.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hologic Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251125405988) on November 25, 2025, and is solely responsible for the information contained therein.
Comments